Orforglipron Calcium Patent Expiration

Orforglipron Calcium was first introduced by Eli Lilly And Co in its drug Foundayo on Apr 1, 2026.


Orforglipron Calcium Patents

Given below is the list of patents protecting Orforglipron Calcium, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

NEW
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Foundayo USRE50455 Sep 26, 2037 Eli Lilly And Co



Orforglipron Calcium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Orforglipron Calcium Generic API Manufacturers

Given below is the list of companies who have filed for Orforglipron Calcium generic, along with the locations of their manufacturing plants worldwide.